Continent files for IPO in Hong Kong

Beijing Continent Pharmaceuticals Inc. filed to list on the Hong Kong stock exchange on April 19. The fibrosis company markets Etuary pirfenidone to treat idiopathic pulmonary fibrosis in China; its pipeline includes two liver fibrosis candidates. It also develops and markets generics...